{
    "project_id": "170951",
    "broad_study_type": "trial",
    "narrow_study_type": "randomized_controlled_trial",
    "trial_phase": "4",
    "observational_timeframe": "N/A",
    "justification": "Our study aims to determine the effect of treatment with an iron-chelating medication on brain iron levels, brain function, and overall health and quality of life in patients with this disorder.",
    "data_type": "canadian",
    "ipd_used": "individual",
    "novelty_statement": "The results of this study will help us to understand whether treatment for iron overload is helpful to patients with this disorder. In addition, the information we learn will be useful for designing studies in other neurodegenerative disorders where iron may play a role, such as Parkinson's Disease.",
    "replication_study": "no",
    "target_population_size": "N/A",
    "age_range": "unclear",
    "gender_focus": "unclear",
    "vulnerable_populations": "yes",
    "rare_disease": "yes",
    "population_description": "patients with neurodegeneration with brain iron accumulation",
    "intervention_category": "drug",
    "intervention_name": "iron-chelating medication",
    "control_type": "placebo",
    "dose_response": "unclear",
    "combination_therapy": "no",
    "personalized_medicine": "no",
    "primary_outcome": "brain iron levels, brain function, overall health and quality of life",
    "primary_outcome_type": "composite",
    "safety_focus": "yes",
    "quality_of_life": "yes",
    "biomarker_endpoints": "yes",
    "time_to_event": "no",
    "composite_endpoint": "yes",
    "ai_machine_learning": "no",
    "digital_health": "no",
    "telemedicine": "no",
    "wearable_technology": "no",
    "big_data_analytics": "no",
    "blockchain": "no",
    "cost_effectiveness": "no",
    "budget_impact": "no",
    "health_technology_assessment": "no",
    "resource_utilization": "no",
    "productivity_outcomes": "no",
    "implementation_science": "no",
    "policy_evaluation": "no",
    "health_system_integration": "no",
    "scalability_assessment": "no",
    "barrier_identification": "no",
    "adaptive_design": "no",
    "bayesian_methods": "no",
    "machine_learning_analysis": "no",
    "novel_biostatistics": "no",
    "patient_reported_outcomes": "yes",
    "real_world_evidence": "no",
    "industry_partnership": "no",
    "patient_engagement": "yes",
    "community_based": "no",
    "indigenous_collaboration": "no",
    "international_collaboration": "no",
    "international_network": "no",
    "regulatory_pathway": "yes",
    "ethics_focus": "yes",
    "consent_innovation": "no",
    "data_sharing": "no",
    "therapeutic_area": "neurology",
    "disease_stage": "unclear",
    "comorbidity_focus": "no",
    "pandemic_related": "no",
    "environmental_health": "no",
    "social_determinants": "no",
    "health_equity": "no",
    "climate_health": "no",
    "urban_rural": "unclear",
    "biobank_use": "no",
    "registry_linkage": "no",
    "cohort_establishment": "no",
    "platform_trial": "no",
    "study_duration": "unclear",
    "multicenter": "no",
    "healthcare_setting": "outpatient",
    "disease_area": "neurodegeneration with brain iron accumulation, Parkinson's disease",
    "methodology_innovation": "randomized controlled trial of iron chelation therapy for a rare neurodegenerative disorder",
    "knowledge_translation_focus": "yes",
    "equity_considerations": "no"
} 